21139 ⎘
Medicinal preparations containing antigens or antibodies Allergens
Sub-classes:ALLERGY TREATMENT
#2FISH ALLERGY ANTIGEN
#3GLYCOTARGETING THERAPEUTICS
#4ALLERGEN DESENSITIZATION METHOD
#5Thermosensitive hydrogel composition
#6VETERINARY PRODUCT
#7COVALENT DUAL-FUNCTIONAL INHIBITORS OF PEANUT ALLERGIES
#8GLYCOTARGETING THERAPEUTICS
#9PSEUDO-VIRAL PARTICLES AND USES OF SAME
#10SUBLINGUAL TABLET AND APPLICATION THEREOF IN DESENSITIZATION THERAPY DRUG
#11Assays For Detecting Peanut Allergies
#12GLYCOTARGETING THERAPEUTICS
#13COMPOSITIONS AND METHODS FOR TREATING GLUTEN-RELATED DISORDERS
#14SKIN MICROENVIRONMENT TARGETED DELIVERY FOR PROMOTING IMMUNE AND OTHER RESPONSES
#15Use of the ultrafiltration for producing purified allergenic extracts
#16COMPOSITIONS AND METHODS FOR ANTIGEN-SPECIFIC TOLERANCE
#17ALLERGY TREATMENT
#18ANTI-ASGR1 POLYPEPTIDES AND METHODS OF USE FOR IMMUNE TOLERANCE
#19ALLERGEN DESENSITIZATION METHOD
#20PEANUT FORMULATIONS AND USES THEREOF
#21COW'S MILK PROTEIN REINTRODUCTION KIT
#22ALLERGY VACCINES BASED ON CONSENSUS ALLERGENS
#23METHODS FOR PREVENTING FOOD SENSITIZATION
#24SINGLE-AND MULTI-EPITOPE PEPTIDE AND MRNA VACCINES TO GENERATE TOLEROGENIC EFFECTS FOR ALLERGIC AND AUTOIMMUNE DISEASE BY TARGETING LIVER SINUSOIDAL ENDOTHELIAL CELLS
#25PEANUT ALLERGEN COMPOSITIONS
#26GLYCOTARGETING THERAPEUTICS
#27ALLERGY ANTIGEN AND EPITOPE THEREOF
#28TREATMENT OF ALLERGY WITH DIMERIC IgA or SECRETORY IgA ANTIGEN IMMUNE COMPLEXES
#29TARGETING JUNCTIONAL EPITHELIUM IN THE GINGIVAL CREVICE FOR IMMUNE MODULATION
#30SELF-ASSEMBLING NANOPARTICLES
#31COMPLETE TOLEROGENIC ADJUVANT AND METHODS OF USING THE SAME
#32TOLERANCE-INDUCING CONSTRUCTS AND COMPOSITION AND THEIR USE FOR THE TREATMENT OF IMMUNE DISORDERS
#33TOLL-LIKE RECEPTOR LIGANDS
#34METHOD OF INDUCING TOLERANCE TO AN ALLERGEN
#35GENERATION OF HUMAN ALLERGEN- AND HELMINTH-SPECIFIC IGE MONOCLONAL ANTIBODIES FOR DIAGNOSTIC AND THERAPEUTIC USE
#36NUCLEIC ACID STRUCTURE UTILIZING SNARE
#37NUCLEIC ACID STRUCTURE UTILIZING SNARE
#38IMPROVED CIRCULAR RNA FOR EXPRESSING THERAPEUTIC PROTEINS
#39Peptide Conjugated Particles
#40COMPOSITIONS AND METHODS FOR FOOD ALLERGY PREVENTION
#41NOVEL IMMUNOTHERAPEUTIC COMPOSITION AND USES THEREOF
#42SUBUNIT VACCINE DELIVERY PLATFORM FOR ROBUST HUMORAL AND CELLULAR IMMUNE RESPONSES
#43PEANUT ALLERGY EPITOPE
#44HYPOALLERGENIC PEANUT ALLERGENS, PRODUCTION AND USE THEREOF
#45ALLERGY TREATMENT
#46NOVEL IMMUNOTHERAPEUTIC MOLECULES AND USES THEREOF
#47NOVEL IMMUNOTHERAPEUTIC MOLECULES AND USES THEREOF
#48IMMUNOTHERAPEUTIC METHOD FOR INCREASING CASHEW TOLERANCE IN A SUBJECT
#49NUCLEIC ACID VECTOR COMPOSITIONS
#50COMPOSITIONS AND METHODS FOR INDUCING IMMUNE TOLERANCE
#51PROTEINS IDENTIFIED FROM BARN DUST EXTRACT FOR THE PREVENTION AND TREATMENT OF DISEASES
#52COMPOSITION FOR IMMUNE TREATMENT OF ALLERGIC DISEASES COMPRISING HOUSE DUST MITE ANTIGENS AND HYALURONIC ACID HYDROGELS AS ACTIVE INGREDIENTS
#53SUBUNIT VACCINE DELIVERY PLATFORM FOR ROBUST HUMORAL AND CELLULAR IMMUNE RESPONSES
#54NANOPARTICLES COMPRISING PEPTIDES INCLUDING AN N-TERMINAL LINKER
#55Self-Assembling Nanoparticles
#56TOLEROGENIC SYNTHETIC NANOCARRIERS FOR ALLERGY THERAPY
#57GENERATION OF HUMAN PEANUT ALLERGEN-SPECIFIC IGE MONOCLONAL ANTIBODIES FOR DIAGNOSTIC AND THERAPEUTIC USE
#58Toothpaste for Delivery of Allergens to Oral Mucosa
#59CO-EXPRESSION OF CONSTRUCTS AND IMMUNOINHIBITORY COMPOUNDS
#60IMMUNOTHERAPEUTIC MOLECULES AND USES THEREOF
#61ALLERGENIC PROTEIN FORMULATIONS FOR IMMUNOTHERAPY
#62COMPOSITIONS AND METHODS FOR IDENTIFICATION OF CROSS-REACTIVE ALLERGENIC PROTEINS AND TREATMENT OF ALLERGIES
#63GENERATION OF HUMAN ALLERGEN- AND HELMINTH-SPECIFIC IGE MONOCLONAL ANTIBODIES FOR DIAGNOSTIC AND THERAPEUTIC USE
#64METHODS OF TREATING ALLERGIES
#65TREATMENT OF PEANUT ALLERGY WITH TOLERIZING NANOPARTICLES
#66MODIFIED VIRUS-LIKE PARTICLES OF BACTERIOPHAGE AP205
#67ALLERGEN DESENSITIZATION METHOD
#68MICROBIAL CONSORTIUM AND USES THEREOF
#69TARGETING JUNCTIONAL EPITHELIUM IN THE GINGIVAL CREVICE FOR IMMUNE MODULATION
#70TOLEROGENIC SYNTHETIC NANOCARRIERS
#71SKIN MICROENVIRONMENT TARGETED DELIVERY FOR PROMOTING IMMUNE AND OTHER RESPONSES
#72COMPOSITIONS AND METHODS FOR IDENTIFICATION OF CROSS-REACTIVE ALLERGENIC PROTEINS AND TREATMENT OF ALLERGIES
#73Food-allergen specific antibody compositions
#74SOYBEAN ALLERGY ANTIGEN
#75FISH ALLERGY ANTIGEN
#76ALLERGY ANTIGEN AND EPITOPE THEREOF
#77PEPTIDE CONJUGATED PARTICLES
#78NANOEMULSION COMPOSITIONS FOR PREVENTING, SUPPRESSING OR ELIMINATING ALLERGIC AND INFLAMMATORY DISEASE
#79Animal Models and Therapeutic Molecules
#80METHODS FOR PREVENTING ORAL SENSITIZATION
#81NANOEMULSION VACCINE COMPOSITIONS AND METHODS FOR SUPPRESSING REACTIVITY TO MULTIPLE FOOD ALLERGENS
#82IMMUNOGENIC PEPTIDES AND THEIR USE IN IMMUNE DISORDERS
#83METHODS AND COMPOSITIONS FOR ADAPTIVE IMMUNE MODULATION
#84HUMAN IGE MONOCLONAL ANTIBODIES TO ANTIBODIES TO ALPHA-GAL (GALACTOSE-A-1,3-GALACTOSE) AND USES THEREFOR
#85ALLERGEN PREPARATION
#86EGG ALLERGY ANTIGEN
#87System and Method for Controlling the Humidity and Pressure in a Luminaire
#88COMPOSITION AND METHOD FOR REDUCING ALLERGIC RESPONSE
#89Nanoparticles comprising peptides including an n-terminal linker
#90SYSTEMS FOR BUCCAL RELEASE OF PROTEINS
#91METHODS FOR MAKING MIXED ALLERGEN COMPOSITIONS
#92IMMUNOGENIC PRODUCT COMPRISING AN IgE FRAGMENT FOR TREATING IgE-MEDIATED INFLAMMATORY DISORDERS
#93Pharmaceutical Composition For Allergen Specific Immunotherapy
#94TOLEROGENIC SYNTHETIC NANOCARRIERS TO REDUCE IMMUNE RESPONSES TO THERAPEUTIC PROTEINS
#95TOLEROGENIC SYNTHETIC NANOCARRIERS TO REDUCE ANTIBODY RESPONSES
#96TOLEROGENIC SYNTHETIC NANOCARRIERS FOR ALLERGY THERAPY
#97ALLERGY ANTIGEN AND EPITOPE FOR SAME
#98PEPTIDE IMMUNOGENS AND FORMULATIONS THEREOF TARGETING MEMBRANE-BOUND IgE FOR TREATMENT OF IgE MEDIATED ALLERGIC DISEASES
#99Animal Models and Therapeutic Molecules
#100Animal Models and Therapeutic Molecules
#101Immunotherapy For The Treatment Of Allergic Disease
#102METHODS AND COMPOSITIONS FOR TREATING AUTOIMMUNE AND ALLERGIC DISORDERS
#103METHODS OF MANUFACTURE OF NUT FLOURS AND FORMULATIONS FOR ORAL IMMUNOTHERAPY
#104MIXED ALLERGEN COMPOSITIONS AND METHODS FOR USING THE SAME
#105COMPOSITIONS COMPRISING NON-VIABLE FECAL MICROBIOTA AND METHODS OF USE THEREOF
#106ANTIGEN OF ALLERGY AND EPITOPE THEREOF
#107COMPOSITION AND METHOD FOR REDUCING ALLERGIC RESPONSE
#108THERAPEUTIC TREATMENT KIT FOR ALLERGIES BASED ON DNA PROFILES
#109VETERINARY PRODUCT
#110METHOD FOR ESTABLISHING EPICUTANEOUSLY SENSITIZED FOOD ALLERGY ANIMAL MODEL
#111MANUFACTURE OF PEANUT FORMULATIONS FOR ORAL DESENSITIZATION
#112GLYCOTARGETING THERAPEUTICS
#113GLYCOTARGETING THERAPEUTICS
#114GLYCOTARGETING THERAPEUTICS
#115METHOD OF INDUCING TOLERANCE TO AN ALLERGEN
#116GLYCOTARGETING THERAPEUTICS
#117COMPOUNDS FOR THE INDUCTION OF ANTIGEN-SPECIFIC IMMUNE TOLERANCE
#118Carbohydrate-Modified Particles and Particulate Formulations for Modulating an Immune Response
#119Toll-like receptor ligands
#120ALLERGY TREATMENT
#121Transdermal patch with separated regions for delivery of immunomodulators
#122SECRETABLE PROTEIN INDUCED IMMUNE TOLERIZATION AND TREATMENT OF AUTOIMMUNE, ALLERGIC AND OTHER DISEASES AND DISORDERS
#123THERAPEUTIC FRACTIONS AND PROTEINS FROM ASTHMA-PROTECTIVE FARM DUST
#124METHOD FOR PREPARING GALACTO-OLIGOSACHARIDES FROM LACTULOSE
#125INDIVIDUALLY CUSTOMIZED ALLERGY CREAM FOR INDIVIDUAL PATIENT PROFILE
#126NUTRITIONAL COMPOSITION FOR IMPROVING IMMUNE FITNESS
#127POLYMERIC NANOPARTICLES THAT TARGET LIVER SINUSOIDAL ENDOTHELIAL CELLS TO INDUCE ANTIGEN-SPECIFIC IMMUNE TOLERANCE
#128METHODS FOR PROVIDING POLYMERIC SYNTHETIC NANOCARRIERS FOR GENERATING ANTIGEN-SPECIFIC TOLERANCE IMMUNE RESPONSES
#129Treatment of insect bite hypersensitivity
#130NOVEL MILK ALLERGY ANTIGEN
#131Generation of human allergen- and helminth-specific IgE monoclonal antibodies for diagnostic and therapeutic use
#132MODIFIED VIRUS-LIKE PARTICLES OF CMV
#133METHODS OF ORAL IMMUNOTHERAPY
#134METHODS AND ARTICLES FOR ALLERGIC DESENSITIZATION VIA THE ORAL MUCOSA
#135Immunotherapeutic composition and uses thereof
#136SELECTIVE LOCAL INHIBITION OF TNFR1-MEDIATED FUNCTIONS AT THE SITE OF ANTIGEN/ALLERGEN PRESENTATION
#137METHOD OF INDUCING ANTIGEN-SPECIFIC TOLERANCE IN A SUBJECT BY ADMINISTERING A COMPOSITION COMPRISING AN APOPTOTIC BODY SURROGATE AND COUPLED IMMUNODOMINANT ANTIGENIC EPITOPES ASSOCIATED WITH AUTOIMMUNE DISEASE
#138MODULATION OF ANTIGEN IMMUNOGENICITY BY ADDITION OF EPITOPES RECOGNIZED BY NKT CELLS
#139Multivalent delivery of immune modulators by liposomal spherical nucleic acids for prophylactic or therapeutic applications
#140Designed Inhibitors of Tight Junction Formation
#141NOVEL ALLERGEN
#142Allergen desensitization method
#143MIXED ALLERGEN COMPOSITIONS AND METHODS FOR USING THE SAME
#144Epitope-Based Approach for Allergy Treatments and Inhibitors for Crohn's Disease
#145SYSTEMIC ALLERGIC RESPONSE RISK ASSESSMENT IN PEANUT ORAL IMMUNOTHERAPY
#146COMPOSITIONS AND METHODS RELATING TO THE TREATMENT OF DISEASES
#147PREDILUTION SETS FOR DISTRIBUTING ANTIGENS
#148Composition comprising vitamin A and non digestible oligosaccharides
#149Methods and Devices for the Treatment of Food Allergies
#150COMPOSITIONS AND METHODS FOR INDUCING IMMUNE TOLERANCE
#151METHOD FOR CLASSIFYING AN ALLERGIC PATIENT AS ELIGIBLE TO ALLERGEN IMMUNOTHERAPY
#152COMBINATION OF SYNTHETIC PEPTIDES WITH AFFINITY TO THE TGF-ß RECEPTOR AND WITH AFFINITY TO THE IL-10 RECEPTOR, PHARMACEUTICAL COMPOSITION AND THEIR USE AS IMMUNOMODULATORS IN THE TREATMENT OF AUTOIMMUNE, INFLAMMATORY OR ALLERGIC DISEASES
#153Method and system for protecting monarch butterflies from pesticides
#154Peptides, Reagents And Methods For Detecting Food Allergy
#155METHOD OF MODULATING MUCOSAL IMMUNOGENICITY
#156Substance for Treating and/or Preventing Intolerance Diseases, and Design Method and Preparation Method thereof
#157MIXED ALLERGEN COMPOSITIONS AND METHODS FOR USING THE SAME
#158PEANUT HYPOALLERGENIC FORMULATIONS FOR DETERMINING THE RISK OF ANAPHYLAXIS
#159IMMUNOGENIC PEPTIDES FOR USE IN THE PREVENTION AND/OR TREATMENT OF INFECTIOUS DISEASES, AUTOIMMUNE DISEASES, IMMUNE RESPONSES TO ALLOFACTORS, ALLERGIC DISEASES, TUMORS, GRAFT REJECTION AND IMMUNE RESPONSES AGAINST VIRAL VECTORS USED FOR GENE THERAPY OR GENE VACCINATION
#160Substance for Treating and/or Preventing Allergic Diseases, and Design Method and Preparation Method thereof
#161PREFILLED MEDICATION DEVICE, METHOD OF MAKING AND USING THE SAME
#162IMMUNE MODULATION
#163Immunotherapeutic molecules and uses thereof
#164Nucleic Acids for Treatment of Allergies
#165MIXED ALLERGEN COMPOSITIONS AND METHODS FOR USING THE SAME
#166METHODS OF INTRODUCING FOOD ALLERGENS
#167ADMINISTRATION OF VACCINES TO SITES OF TEMPORALLY INDUCED CELL-MEDIATED HYPERSENSITIVITY REACTIONS, TO FACILITATE THE DEVELOPMENT OF PROTECTIVE SENSITIZATION AGAINST INFECTIOUS DISEASES AND CANCERS
#168Human antibodies to Fel d1 and methods of use thereof
#169METHODS, DEVICE AND REAGENTS TO TREAT ALLERGY AND AUTOIMMUNE DISEASE
#170METHODS FOR MAKING MIXED ALLERGEN COMPOSITIONS
#171IMMUNOGENIC PEPTIDES WITH IMPROVED OXIDOREDUCTASE MOTIFS
#172Nanoemulsion compositions for preventing, suppressing or eliminating allergic and inflammatory disease
#173NANOEMULSION COMPOSITIONS HAVING ENHANCED PERMEABILITY
#174Generation of human allergen- and helminth-specific IgE monoclonal antibodies for diagnostic and therapeutic use
#175Native whey protein for reducing allergy
#176METHODS AND REAGENTS TO TREAT ALLERGY
#177Nucleic acid for treating mite allergy
#178Immune Tolerance-Inducing Agent and Therapeutic or Prophylactic Agent for Allergic Disorder
#179EGG ALLERGY ANTIGEN
#180Methods and devices for the treatment of food allergies
#181MICROBIAL CONSORTIUM AND USES THEREOF
#182SUBUNIT VACCINE DELIVERY PLATFORM FOR ROBUST HUMORAL AND CELLULAR IMMUNE RESPONSES
#183Composition for diagnosing allergies to mites, method of diagnosing allergies to mites, and composition for preventing or treating allergies to mites
#184LAMP CONSTRUCTS COMPRISING ALLERGENS
#185Assays For Detecting Peanut Allergies
#186SELF-EMULSIFYING DOSAGE FORMS OF ALLERGEN AND THEIR PREPARATION THEREOF
#187SELF-EMULSIFYING SOLID ORAL DOSAGE FORMS OF ALLERGEN AND THEIR PREPARATION THEREOF
#188Mixed allergen compositions and methods for using the same
#189BIOMARKER METHODS FOR TREATMENT OF ATOPIC DISEASE BY IMMUNOTHERAPY
#190Method and means for diagnosing and treating allergy
#191Carbohydrate-Modified Particles and Particulate Formulations for Modulating an Immune Response
#192MODIFIED EPITOPES FOR BOOSTING CD4+ T-CELL RESPONSES
#193Toothpaste for delivering allergens to oral mucosa
#194Method and system for protecting honey bees from pesticides
#195NUCLEIC ACID FOR TREATING MITE ALLERGY
#196Nanoallergens and uses thereof
#197MODULAR ANTIGEN TRANSPORTATION MOLECULES AND USES THEREOF IN ANIMALS
#198Treatment and prevention of house dust mite allergies
#199IGE EPITOPE-LIKE PEPTIDES AND USES THEREOF
#200Compositions against cat allergy
#201PREDILUTION SETS FOR DISTRIBUTING ANTIGENS
#202VETERINARY PRODUCT
#203PEPTIDE IMMUNOGENS OF IL-31 AND FORMULATIONS THEREOF FOR THE TREATMENT AND/OR PREVENTION OF ATOPIC DERMATITIS
#204IMMUNE MODULATION
#205Composition and method for reducing allergic response
#206METHODS OF USING A VACCINE COMPOSITION CONTAINING SYNTHETIC ADJUVANT
#207VACCINE COMPOSITION CONTAINING SYNTHETIC ADJUVANT
#208Peanut formulations and uses thereof
#209BABY FOOD PRODUCTS CONTAINING ALLERGENIC PROTEINS AND METHODS OF DELIVERING SAME
#210Toll-like receptor ligands
#211Method for presymptomatic diagnosis of coeliac disease and gluten sensitivity
#212Topical hyper-allergenic composition and method of treating using the same
#213Animal Models and Therapeutic Molecules
#214Method for treating skin diseases using a humanized antibody that binds to vimentin
#215Allergen desensitization method
#216Animal Models and Therapeutic Molecules
#217Animal Models and Therapeutic Molecules
#218Recombinant hypoallergenic Equ c 1 polypeptides for use in the immunotherapy of horse allergy
#219Treatment and prevention of seed allergies
#220Animal Models and Therapeutic Molecules
#221MILK-BASED PROTEIN HYDROLYSATES AND INFANT FORMULAE AND NUTRITIONAL COMPOSITIONS MADE THEREOF
#222Peptide conjugated particles
#223Immunogenic peptides and their use in immune disorders
#224METHODS AND REAGENTS TO TREAT ALLERGY
#225Mixed allergen compositions and methods for using the same
#226Allergenic protein formulations for immunotherapy
#227Pollen grains for treatment of peanut and other allergies
#228Method and system for protecting honey bees from pesticides
#229Compositions for Immunotherapy
#230ALLERGY ANTIGEN AND EPITOPE FOR SAME
#231METHODS AND THERAPEUTIC COMPOSITIONS FOR TREATMENT OF ALLERGY
#232Methods for making mixed allergen compositions
#233Treatment of insect bite hypersensitivity
#234METHODS OF POPULATING PRECIPITATED PARTICLES OF A MODIFIED OR SYNTHESIZED SUBSTANCE IN A TISSUE
#235PREVENTION OF ALLERGY
#236Synthetic composition for reducing allergy symptoms
#237METHOD OF INDUCING TOLERANCE TO AN ALLERGEN
#238ALLERGY ANTIGEN AND EPITOPE THEREOF
#239Mixed allergen compositions and methods for using the same
#240Therapeutic treatment kit for allergies based on DNA profiles
#241Immunotherapy for the treatment of allergic disease
#242Modified virus-like particles of CMV
#243Process for the preparation of allergenic extracts
#244Methods and devices for the treatment of food allergies
#245Recombinant type 2 allergen protein and its preparation method and application
#246Glycotargeting therapeutics
#247Glycotargeting therapeutics
#248METHODS FOR EFFECTIVELY AND RAPIDLY DESENSITIZING ALLERGIC PATIENTS
#249Glycotargeting therapeutics
#250Manufacture of peanut formulations for oral desensitization
#251Variant recombinant dermatophagoides pteronyssinus type 1 allergen protein and its preparation method and application
#252IMMUNOGENIC PROTEINS AND FRAGMENTS THEREOF FROM ALLERGENIC MITES
#253Glycotargeting therapeutics
#254Compositions for treating inflammation and uses thereof
#255Composition and method for reducing allergic response
#256Pharmaceutical product comprising mite allergen extract(s) and a method for the manufacture thereof
#257TOLEROGENIC SYNTHETIC NANOCARRIERS FOR GENERATING CD8+ REGULATORY T CELLS
#258TOLEROGENIC SYNTHETIC NANOCARRIERS FOR ANTIGEN-SPECIFIC DELETION OF T EFFECTOR CELLS
#259Compositions and methods for inducing immune tolerance
#260Subunit vaccine delivery platform for robust humoral and cellular immune responses
#261Pharmaceutical composition comprising a polymeric carrier cargo complex and at least one protein or peptide antigen
#262METHOD FOR DILUTING AND MIXING IMMUNOMODULATORS INTO A CONSOLIDATED COMPOUND
#263Multivalent delivery of immune modulators by liposomal spherical nucleic acids for prophylactic or therapeutic applications
#264PEANUT ORAL IMMUNOTHERAPY WITH MAINTENANCE DOSE
#265Immunomodulatory compositions and methods of use thereof
#266Toothpaste for delivery of allergens to oral mucosa
#267Predilution sets for distributing antigens
#268Recombinant type 2 allergen protein and its preparation method and application
#269PHARMACEUTICAL COMBINATIONS FOR IMMUNOTHERAPY
#270Mixed allergen compositions and methods for using the same
#271Mixed allergen compositions and methods for using the same
#272INHIBITION OF UNFOLDED PROTEIN RESPONSE FOR SUPPRESSING OR PREVENTING ALLERGIC REACTION TO FOOD
#273Peptides And Methods For Detecting Peanut Allergies
#274Generation of human allergen- and helminth-specific IgE monoclonal antibodies for diagnostic and therapeutic use
#275Predilution sets for distributing antigens
#276Nucleic acids for treatment of allergies
#277Nanoparticles having poly(ester amide) polymer cores as drug delivery vehicles
#278IMMUNIZING PEPTIDE, METHOD FOR PRODUCING IMMUNIZING PEPTIDE, PHARMACEUTICAL COMPOSITION FOR IMMUNE DISEASE CONTAINING SAME, AND METHOD FOR TREATING IMMUNE DISEASE
#279IMMUNOMODULATORY COMPOSITIONS, PROCESSES FOR MAKING THE SAME, AND METHODS FOR INHIBITING CYTOKINE STORMS
#280Allergen desensitization method
#281Method and system for treating cancer and other age-related diseases by extending the healthspan of a human
#282Nucleic Acids for Treatment of Peanut Allergies
#283SELECTIVE LOCAL INHIBITION OF TNFR1-MEDIATED FUNCTIONS AT THE SITE OF ANTIGEN/ALLERGEN PRESENTATION
#284FHSS hotspot device and methods
#285LIQUID ALLERGEN COMPOSITIONS AND METHODS FOR MAKING THE SAME
#286Methods and compositions for adaptive immune modulation
#287Peptide conjugated particles for the treatment of inflammation
#288NUCLEIC ACID COMPRISING OR CODING FOR A HISTONE STEM-LOOP AND A POLY(A) SEQUENCE OR A POLYADENYLATION SIGNAL FOR INCREASING THE EXPRESSION OF AN ENCODED ALLERGENIC ANTIGEN OR AN AUTOIMMUNE SELF-ANTIGEN
#289Immunomodulator for hypersensitivity reaction to house dust mite-derived allergen
#290METHODS AND REAGENTS TO TREAT AUTOIMMUNE DISEASES AND ALLERGY
#291Compositions of food allergens
#292Treatment of canine atopic dermatitis
#293Immunogenic proteins and fragments thereof from allergenic mites
#294Composition for oral delivery of bioactive agents
#295COMPOSITIONS AND METHODS FOR TOLERIZING CELLULAR SYSTEMS
#296Peanut formulations and used thereof
#297Epitope
#298PROGRAMMING OF CELLS FOR TOLEROGENIC THERAPIES
#299HYPO-ALLERGENIC CROSS-LINKED PROTEINS FOR USE IN THE PREVENTION OF AN ALLERGY AGAINST MILK-PROTEINS AND FOR USE IN THE INDUCTION OF ORAL TOLERANCE
#300Peanut formulations and uses thereof